The influence of the Travalert® dosing aid on medical treatment compliance and the quality of life of glaucoma patients

Sánchez-Pulgarín, M.; Martínez-de-la-Casa, J.M.; Escalada, A.; Sáenz-Francés, F.; García‐Feijoó, Julián; Sánchez, J. García

doi:10.1016/j.oftale.2011.04.006

Cited by 1 publication

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[1][2][3][4][5][6][7] Even in cases where a doctor has asked patients direct questions regarding eye drop regimen compliance, and electronic monitoring has been employed, drug delivery failure is still an issue. [8][9][10][11][12][13] Several devices have been developed to help patients adhere to and monitor eye drop regimens, [12][13][14][15] although none of these techniques for monitoring compliance are meant to determine whether the drops get into the eye; rather they measure if a patient attempts to administer the eye drops.…”

Section: Introductionmentioning

confidence: 99%

A novel eye drop application monitor to assess patient compliance with a prescribed regimen: a pilot study

Eaton

Gordon

konowal³

et al. 2015

Eye

View full text Add to dashboard Cite

Purpose To assess the ability of a novel imaging device to allow physicians to personalize therapeutic regimens based on objective patient drop administration data. Methods A novel imaging system was used to record video of the drop technique of subjects in clinic (n = 25) or at home (n = 17) for 1 week. Video assessment by a reading center was compared with patient reporting and their prescribed regimen with respect to how many drops were applied and how many landed in the eye. Results Reading center assessment of both drops dispensed and drops landing in the eye was significantly different from the prescribed regimen in the clinic (P d = 0.005, P i o0.001, respectively) and at-home arms (P d = 0.003, P i o0.001, respectively). Conclusions This imaging system is a powerful tool to help physicians tailor patient therapy more accurately, to help researchers evaluate new drop therapies with objective rather than subjective data, and to potentially facilitate better patient training for improved drug delivery.

show abstract